Nationwide Fund Advisors’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-7,278
Closed -$226K 1805
2017
Q3
$226K Sell
7,278
-1,149
-14% -$31.2K ﹤0.01% 2580
2017
Q2
$237K Buy
8,427
+1,149
+16% +$27.7K ﹤0.01% 2560
2017
Q1
$175K Sell
7,278
-462
-6% -$11.3K ﹤0.01% 2646
2016
Q4
$197K Sell
7,740
-539
-7% -$14.2K ﹤0.01% 2610
2016
Q3
$249K Hold
8,279
﹤0.01% 2527
2016
Q2
$194K Hold
8,279
﹤0.01% 2628
2016
Q1
$152K Sell
8,279
-517
-6% -$9.73K ﹤0.01% 2654
2015
Q4
$178K Hold
8,796
﹤0.01% 2617
2015
Q3
$192K Hold
8,796
﹤0.01% 2582
2015
Q2
$206K Sell
8,796
-593
-6% -$14.9K ﹤0.01% 2695
2015
Q1
$244K Sell
9,389
-487
-5% -$11.6K ﹤0.01% 2595
2014
Q4
$218K Sell
9,876
-10,786
-52% -$229K ﹤0.01% 2587
2014
Q3
$375K Buy
20,662
+95
+0.5% +$1.9K ﹤0.01% 2372
2014
Q2
$441K Sell
20,567
-30,267
-60% -$648K ﹤0.01% 2330
2014
Q1
$1.15M Sell
50,834
-962
-2% -$23.5K 0.01% 1661
2013
Q4
$1.26M Sell
51,796
-7,732
-13% -$182K 0.01% 1740
2013
Q3
$1.42M Buy
59,528
+46,730
+365% +$1M 0.01% 1653
2013
Q2
$256K Buy
+12,798
New +$320K ﹤0.01% 2372

Other funds holding SRDX

Nationwide Fund Advisors's SRDX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 7,278 shares — an estimated $226K sold.

Nationwide Fund Advisors first reported a position in SRDX in Q2 2013 and held it in 18 quarters. The position peaked at $1.42M in Q3 2013. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,278 Surmodics shares in Q4 2017, an estimated $226K.
  • Nationwide Fund Advisors first reported a position in Surmodics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Surmodics position peaked at $1.42M in Q3 2013.
  • 115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.